Monday, February 8, 2010

David Agus Talks Cancer Research Strategy at TEDMED 2009

Filed under: in the news...

David Agus, professor of medicine at the University of Southern California and co-founder of personal genomics company Navigenics, spoke at last year's TEDMED about the state of available cancer therapy treatments and how far they've come from fifty years ago. Turns out the progress made so far has not been very promising and Agus is calling for a new strategy in attacking this multifaceted disease.

Link: TEDMED...

                (0)

Name:


Email Address
(will not be published):


URL:

Remember personal info?
(anonymous comments allowed)

Yes No

Comments:

Verification (needed to reduce spam):

Click the "Post" button only once!